Vision RT

Vision RT

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20.5M

Overview

Vision RT is the pioneer and market leader in Surface Guided Radiation Therapy (SGRT), a technology that uses 3D cameras to track patient position without physical markers or ionizing radiation. With over 3,000 systems installed globally, including in 24 of the top 25 US cancer hospitals, the company's platform addresses critical needs in radiotherapy: enhancing patient safety, improving treatment accuracy, and increasing clinical workflow efficiency. The company has a global presence, nearly 400 employees, and a growing portfolio that extends from patient setup to real-time dose visualization, positioning it at the forefront of innovation in radiation oncology.

Oncology

Technology Platform

Surface Guided Radiation Therapy (SGRT) platform using non-invasive, non-ionizing 3D surface imaging for real-time patient tracking and motion management throughout the radiotherapy workflow. Includes systems for CT simulation (SimRT), treatment planning (MapRT), treatment delivery (AlignRT), and real-time dose visualization (DoseRT).

Funding History

2
Total raised:$20.5M
Series B$15M
Series A$5.5M

Opportunities

Global growth in cancer incidence and adoption of advanced radiotherapy techniques drives demand for precise patient positioning.
Expansion into proton therapy centers and community hospitals presents significant new markets.
The trend towards tattoo-free, patient-friendly radiotherapy aligns perfectly with Vision RT's value proposition.

Risk Factors

Increasing competition from other medical device firms and linac vendors integrating surface guidance.
Market adoption speed in cost-sensitive community clinics may be slower than in top-tier centers.
Success depends on continuous seamless integration with various radiotherapy hardware and software systems from other vendors.

Competitive Landscape

Vision RT is the pioneer and market leader in Surface Guided Radiation Therapy (SGRT). Competition includes other specialized SGRT providers (e.g., C-RAD) and major linear accelerator vendors (e.g., Varian, a Siemens Healthineers company, and Elekta) who may develop or bundle their own surface imaging solutions. Vision RT's deep focus, extensive clinical evidence, and broad platform integration are key differentiators.